Piramal Pharma (NSE:PPLPHARMA) Other Long-Term Liabilities : ₹4,294 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Other Long-Term Liabilities?

Piramal Pharma's other long-term liabilities for the quarter that ended in Mar. 2024 was ₹4,294 Mil.

Piramal Pharma's quarterly other long-term liabilities declined from Sep. 2023 (₹4,645 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹4,294 Mil).

Piramal Pharma's annual other long-term liabilities increased from Mar. 2022 (₹3,480 Mil) to Mar. 2023 (₹4,206 Mil) and increased from Mar. 2023 (₹4,206 Mil) to Mar. 2024 (₹4,294 Mil).

Piramal Pharma Other Long-Term Liabilities Historical Data

The historical data trend for Piramal Pharma's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Other Long-Term Liabilities Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Other Long-Term Liabilities

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial							-	-	-	-	-

Piramal Pharma Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Piramal Pharma Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma (NSE:PPLPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

543635:India

Address

Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramal.com

Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (NSE:PPLPHARMA) Headlines

No Headlines